SEC Form 4 · accession 0001179110-16-028450
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nesli Basgoz
Director
Period of report
Aug 5, 2016
Accepted (ET)
Aug 9, 2016 · 3:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1 | Aug 5, 2016 | M | 1,889 | $97.62 | A | 6,672 | D | |
| Ordinary Shares, par value $0.0001 | Aug 5, 2016 | S | 758 | $253.02 | D | 5,914 | D | |
| Ordinary Shares, par value $0.0001F2,F3 | Aug 8, 2016 | A | 201 | $248.31 | A | 6,115 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $97.62 | Aug 5, 2016 | M | 1,889 | A | — | Aug 7, 2016 | Ordinary Shares | 1,889 | 12,878 | D |
Explanation of responses
- F1This option award was scheduled to expire pursuant to its terms on August 7, 2016, and was exercised on the last trading day prior to expiration.
- F2These restricted stock units shall vest 100% on the earlier of (i) the day before the 2017 Annual Shareholder Meeting or (ii) May 4, 2017.
- F3Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
- F4This option became vested and exercisable in four equal installments commencing on August 7, 2006.